Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 40 million people worldwide, with over 1 million deaths as of October 2020 and with multiple efforts in the development and testing of antiviral drugs and vaccines under way. In order to gain insights into SARS-CoV-2 evolution and drug targets, we investigated how and to what extent the SARS-CoV-2 genome sequence differs from those of other well-characterized human and animal coronavirus genomes, as well as how polymorphic SARS-CoV-2 genomes are generally. We ultimately sought to identify features in the SARS-CoV-2 genome that may contribute to its viral replication, host pathogenicity, and vulnerabilities. Our analyses suggest the presence of unique sequence signatures in the 3' untranslated region (3'-UTR) of betacoronavirus lineage B, which phylogenetically encompasses SARS-CoV-2 and SARS-CoV as well as multiple groups of bat and animal coronaviruses. In addition, we identified genome-wide patterns of variation across different SARS-CoV-2 strains that likely reflect the effects of selection. Finally, we provide evidence for a possible host-microRNA-mediated interaction between the 3'-UTR and human microRNA hsa-miR-1307-3p based on the results of multiple computational target prediction analyses and an assessment of similar interactions involving the influenza A H1N1 virus. This interaction also suggests a possible survival mechanism, whereby a mutation in the SARS-CoV-2 3'-UTR leads to a weakened host immune response. The potential roles of host microRNAs in SARS-CoV-2 replication and infection and the exploitation of conserved features in the 3'-UTR as therapeutic targets warrant further investigation.IMPORTANCE The coronavirus disease 2019 (COVID-19) outbreak is having a dramatic global effect on public health and the economy. As of October 2020, SARS-CoV-2 has been detected in over 189 countries, has infected over 40 million people, and is responsible for more than 1 million deaths. The genome of SARS-CoV-2 is small but complex, and its functions and interactions with human host factors are being studied extensively. The significance of our study is that, using extensive SARS-CoV-2 genome analysis techniques, we identified potential interacting human host microRNA targets that share similarity with those of influenza A virus H1N1. Our study results will allow the development of virus-host interaction models that will enhance our understanding of SARS-CoV-2 pathogenesis and motivate the exploitation of both the interacting viral and host factors as therapeutic targets.

SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication

COVID-19 Metabolism: Mechanisms and Therapeutic Targets.

SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19

Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication

COVID-19 and One-Carbon Metabolism

SARS-CoV-2 exploits host DGAT and ADRP for efficient replication

Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2.

Patient-derived SARS-CoV-2 Mutations Impact Viral Replication Dynamics and Infectivity in Vitro and with Clinical Implications in Vivo

Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View

SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis

SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection

Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets

Folic Acid Restricts SARS-CoV-2 Invasion by Methylating ACE2

Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

The global succinylation of SARS-CoV-2–infected host cells reveals drug targets

Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows

SARS-CoV-2 infection dysregulates NAD metabolism

Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions

Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis